Evidence map›Paper›PMID 25056629›Full record

ArticleMarine drugs2014

Bioactive cembrane derivatives from the Indian Ocean soft coral, Sinularia kavarattiensis.

Katja-Emilia Lillsunde, Carmen Festa, Harshada Adel, Simona De Marino, Valter Lombardi, Supriya Tilvi, Dorota A Nawrot, Angela Zampella, Lisette D'Souza, Maria Valeria D'Auria and 1 more

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Asymmetric Total Synthesis of (+)-Ineleganolide.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Katja-Emilia LillsundeCentre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O. Box 56, University of Helsinki, Helsinki FI-00014, Finland. katja-emilia.lillsunde@helsinki.fi.
Carmen FestaDepartment of Pharmacy, University of Naples Federico II (USNF), Naples I-80131, Italy. carmen.festa@unina.it.
Harshada AdelCSIR-National Institute of Oceanography, Dona Paula, Goa 403004, India. hadel@nio.org.
Simona De MarinoDepartment of Pharmacy, University of Naples Federico II (USNF), Naples I-80131, Italy. sidemari@unina.it.
Valter LombardiEuroEspes Biotechnology, Department of Cellular Immunology, Bergondo 15165, A Coruña, Spain. biotecnologia@ebiotec.com.
Supriya TilviCSIR-National Institute of Oceanography, Dona Paula, Goa 403004, India. supriyatilvi@nio.org.
Dorota A NawrotCentre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O. Box 56, University of Helsinki, Helsinki FI-00014, Finland. dorota.nawrot@helsinki.fi.
Angela ZampellaDepartment of Pharmacy, University of Naples Federico II (USNF), Naples I-80131, Italy. azampell@unina.it.
Lisette D'SouzaCSIR-National Institute of Oceanography, Dona Paula, Goa 403004, India. lisette@nio.org.
Maria Valeria D'AuriaDepartment of Pharmacy, University of Naples Federico II (USNF), Naples I-80131, Italy. madauria@unina.it.
Päivi TammelaCentre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O. Box 56, University of Helsinki, Helsinki FI-00014, Finland. paivi.tammela@helsinki.fi.
University of Naples Federico II · ITNational Institute of Oceanography · INUniversity of Helsinki · FIEuroEspes Biomedical Research Center · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine organisms and their metabolites represent a unique source of potential pharmaceutical substances. In this study, we examined marine-derived substances for their bioactive properties in a cell-based Chikungunya virus (CHIKV) replicon model and for in vitro anti-inflammatory activity. In the screening of a marine sample library, crude extracts from the Indian soft coral, Sinularia kavarattiensis, showed promising activity against the CHIKV replicon. Bioassay-guided chemical fractionation of S. kavarattiensis resulted in the isolation of six known norcembranoids (1-6) and one new compound, named kavaranolide (7). The structures were elucidated on the basis of NMR and MS spectroscopic data. Compounds 1-3 and 5-7 were evaluated for their replicon-inhibiting potential in the CHIKV model by using a luminescence-based detection technique and live cell imaging. Compounds 1 and 2 showed moderate inhibition of the CHIKV replicon, but imaging studies also revealed cytotoxic properties. Moreover, the effects of the isolated compounds on primary microglial cells, an experimental model for neuroinflammation, were evaluated. Compound 2 was shown to modulate the immune response in microglial cells and to possess potential anti-inflammatory properties by dose-dependently reducing the release of pro- and anti-inflammatory cytokines.

Indexed as

AnimalsAnthozoaAnti-Inflammatory AgentsAntiviral AgentsChikungunya virusDiterpenesDose-Response Relationship, DrugStructure-Activity RelationshipAnti-Inflammatory AgentsAntiviral AgentsDiterpenes

Identifiers

PMID25056629
PMCPMC4113814
OpenAlexW2157987228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.